Dr Matthew E Midcap, MD | |
4150 Barrett Blvd, Ephrata, PA 17522-8979 | |
(717) 738-6782 | |
(717) 738-6512 |
Full Name | Dr Matthew E Midcap |
---|---|
Gender | Male |
Speciality | Anesthesiology - Pain Medicine |
Location | 4150 Barrett Blvd, Ephrata, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972602043 | NPI | - | NPPES |
001193153 | Medicaid | PA | |
18436 | Other | SC | LICENSE NO. |
14731 | Other | WV | LICENSE NO. |
18235 | Other | ABA CERTIFICATE NO. |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD045904L (Pennsylvania) | Secondary |
207LP2900X | Anesthesiology - Pain Medicine | MD045904L (Pennsylvania) | Primary |
Entity Name | Wellspan Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
Australian men care about erection problems, perhaps more so than possible cardiovascular disease. This may present an opportunity to improve communication about the benefits of weight loss.
A new research report published in the December 2009 print issue of The FASEB Journal could one day give men similar type of control over their fertility that women have had since the 1960s. That's because scientists have found how and where androgenic hormones work in the testis to control normal sperm production and male fertility. This opens a promising avenue for the development of "the pill" for men. The discovery also offers hope to those who cannot have children because of low sperm counts.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.
Studying just eight families worldwide, the international team of researchers have discovered a genetic defect that results in profound depression and parkinsonism in a disorder known as Perry syndrome.
Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.
› Verified 6 days ago
Entity Name | Anesthesia And Pain Of Assoc Of No Lancaster Cty |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134228869 PECOS PAC ID: 1153307061 Enrollment ID: O20040629001225 |
News Archive
Australian men care about erection problems, perhaps more so than possible cardiovascular disease. This may present an opportunity to improve communication about the benefits of weight loss.
A new research report published in the December 2009 print issue of The FASEB Journal could one day give men similar type of control over their fertility that women have had since the 1960s. That's because scientists have found how and where androgenic hormones work in the testis to control normal sperm production and male fertility. This opens a promising avenue for the development of "the pill" for men. The discovery also offers hope to those who cannot have children because of low sperm counts.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.
Studying just eight families worldwide, the international team of researchers have discovered a genetic defect that results in profound depression and parkinsonism in a disorder known as Perry syndrome.
Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Matthew E Midcap, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 738-6782 | Dr Matthew E Midcap, MD 4150 Barrett Blvd, Ephrata, PA 17522-8979 Ph: (717) 738-6782 |
News Archive
Australian men care about erection problems, perhaps more so than possible cardiovascular disease. This may present an opportunity to improve communication about the benefits of weight loss.
A new research report published in the December 2009 print issue of The FASEB Journal could one day give men similar type of control over their fertility that women have had since the 1960s. That's because scientists have found how and where androgenic hormones work in the testis to control normal sperm production and male fertility. This opens a promising avenue for the development of "the pill" for men. The discovery also offers hope to those who cannot have children because of low sperm counts.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.
Studying just eight families worldwide, the international team of researchers have discovered a genetic defect that results in profound depression and parkinsonism in a disorder known as Perry syndrome.
Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.
› Verified 6 days ago
Robert A Garvin, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-859-4533 Fax: 717-859-4475 | |
Brian R Melamed, PH.D., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-859-4533 Fax: 717-859-4475 | |
Alan Berkowitz, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-859-4533 | |
Chang Su Lee, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Avenue, Ephrata, PA 17522 Phone: 717-859-4533 Fax: 717-859-4475 | |
Dr. Ikenna K. Obioma, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-733-0311 Fax: 717-721-5861 | |
Dr. Jeffrey B Musser, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-733-0311 | |
Sarah May Manmiller, Anesthesiology Medicare: Medicare Enrolled Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-733-0311 Fax: 717-721-5861 |